UNASSIGNED: 265 Background: Recent initiatives to improve @entity1 safety and reduce healthcare costs have focused on preventing hospital readmissions. Historically, @entity1 treated with allogeneic @entity8 ( @entity8 ) have high rates of hospital readmission. The purpose of this study was to identify the incidence and reasons for readmissions in allogeneic @entity8 @entity1 as well as associated risk factors for readmission. METHODS: A retrospective review of @entity1 receiving a myeloablative or reduced intensity conditioning (RIC) @entity8 at Dana Farber/Brigham and @entity1 's Hospital between January 1, 2005 and December 31, 2010 was performed. Reasons for readmission, along with sociodemographic, disease, and transplant related variables were evaluated. Potential risk factors for readmission were determined by multivariate regression analysis. RESULTS: A total of 1,097 @entity8 @entity1 were reviewed. In the myeloablative group, 130 of 495 (26.3%) @entity1 were readmitted within 30 days of discharge, among whom the majority of @entity1 (71.5%) had one readmission. For @entity68903 , 105 of 602 (17.4%) @entity1 were readmitted within 30 days, among whom 62.9% of @entity1 had one readmission. In the myeloablative group, the most frequent reasons for readmission were @entity221 without identified source (40.7%) and @entity2132 ( @entity2132 ) (23.7%). Similarly, the most common diagnoses at readmission in the @entity68903 were @entity221 without source (54.9%) and @entity2132 (11.0%). In the @entity68903 , a logistic regression model of the probability of being readmitted suggested active disease (OR 2.0, p=0.005), a mismatched donor (OR 2.4, p=0.029), @entity281 during the index admission (OR 5.8, p<0.0001) and non-private insurance (OR 1.8, p=0.025) are significant factors for readmission within 30 days. CONCLUSIONS: Infection and @entity221 without a source were the most common causes of readmission after @entity8 . In the RIC group, @entity66 , transplant, and sociodemographic factors were associated with readmission. Better defining the risk factors for readmission in this population will allow for more transitional care resources to be focused on high risk @entity1 .

Readmissions following allogeneic XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'Women', 'patient'] @entity8 :: ('MESH:D007674', 'Disease') :: ['hematopoietic stem cell transplantation', 'HSCT'] @entity66 :: ('MESH:D004194', 'Disease') :: ['multiple disease'] @entity68903 :: ('9743', 'Gene') :: ['RICs'] @entity281 :: ('MESH:D007239', 'Disease') :: ['infection'] @entity2132 :: ('MESH:D006086', 'Disease') :: ['GVHD', 'graft versus host disease'] @entity221 :: ('MESH:D005334', 'Disease') :: ['infection or fever', 'fever']
@entity8 :: (MESH:D007674,Disease) :: ['hematopoietic stem cell transplantation']
